UNSPSC 51102874: Sulfabenzamide/sulfacetamide/sulfathiazole/urea

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GU300. This VA Drug Class (GU300) classifies this compound as belonging to the group ANTI-INFECTIVES, VAGINAL.

UNSPSC 51102874 Sulfabenzamide/sulfacetamide/sulfathiazole/urea is a Commodity code that does not align with the state and local opportunities recently tagged under it. The code nominally describes a specific pharmaceutical compound used topically for skin infections and other dermatological conditions, yet the recent solicitations posted under this code—a Seminole County naloxone and drug deactivation systems procurement, a Texas HHS direct-to-manufacturer prescription program RFI, a Tampa Fire Department medical and first aid supplies bid, and a Minnesota Multistate Cooperative Purchasing Alliance generic pharmaceuticals and OTC products contract—show no procurement activity for the compound itself or related antimicrobial sulfonamide products. The mismatch between the code's narrow pharmaceutical scope and the broad health-supply and pharmacy-benefit solicitations suggests either a tagging error or that this code sees minimal relevant state and local procurement activity under its actual definition.

No recent state and local opportunities specifically soliciting sulfabenzamide/sulfacetamide/sulfathiazole/urea formulations appear in the available records. If your firm produces or distributes this compound for institutional health-system, clinic, or correctional-facility use, monitor cooperative purchasing vehicles—such as MMCAP or similar state-level group purchasing organizations—for future pharmaceutical RFPs that may include dermatological agents. Verify product tagging accuracy with issuing bodies before pursuing opportunities listed under this code, as the current data suggests classification drift rather than active demand.